The National Academies of Sciences, Engineering and Medicine has released a report summarizing its Sept. 5-6 workshop on medical product shortages during disasters and opportunities to better predict, prevent and respond to shortages. The Department of Health and Human Services asked NASEM to convene the workshop in response to the shortage of intravenous saline solution exacerbated by the 2017 hurricane season. AHA, which participated on the workshop planning committee, last year called for a comprehensive strategy to address these and other critical drug shortages. In July, Food and Drug Administration Commissioner Scott Gottlieb, M.D., convened an interagency task force to report to Congress on the root causes of drug shortages and recommend new federal authorities to address them. FDA will hold a public meeting Nov. 27 to receive stakeholder input on the issue.

Related News Articles

Headline
Hospitals spend close to $360 million each year to manage drug shortages, according to a study released this week by Vizient Inc.
Headline
The House Judiciary Committee yesterday approved by voice vote the Creating and Restoring Equal Access to Equivalent Samples Act (H.R. 965).
Headline
Civica Rx, the not-for-profit generic drug company, officially opened its headquarters last week in Lehi, Utah.
Headline
The Food and Drug Administration Friday released draft guidance on how drug developers can apply for the agency’s Competitive Generic Therapies designation.
Headline
The AHA today submitted to the Food and Drug Administration legislative, regulatory and best practice recommendations to address new and chronic prescription…
Headline
The AHA, American Society of Anesthesiologists, American Society of Clinical Oncology, American Society of Health-System Pharmacists, and Institute for Safe…